An Umbrella Study to Determine the Safety and Efficacy of Various Monotherapy or Combination Therapies in Neoadjuvant Urothelial Carcinoma

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
This is a multicenter, open-label, randomized, Phase 2 umbrella study of various neoadjuvant treatment combinations in participants who have muscle-invasive urothelial carcinoma of the bladder and are cisplatin-ineligible or refusing cisplatin therapy and awaiting radical cystectomy.
Epistemonikos ID: 0c149f7dbd5af08a300069c1e97dc94a6e8499d7
First added on: Oct 02, 2023